anastrozole has been researched along with Focal Segmental Glomerulosclerosis in 1 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Anastrozole is a selective aromatase inhibitor and is used for the hormonal treatment of postmenopausal breast cancer." | 7.74 | Anastrozole-associated sclerosing glomerulonephritis in a patient with breast cancer. ( Akgul, B; Camci, C; Kalender, ME; Karakok, M; Sevinc, A; Turk, HM, 2007) |
| "Anastrozole is a selective aromatase inhibitor and is used for the hormonal treatment of postmenopausal breast cancer." | 3.74 | Anastrozole-associated sclerosing glomerulonephritis in a patient with breast cancer. ( Akgul, B; Camci, C; Kalender, ME; Karakok, M; Sevinc, A; Turk, HM, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kalender, ME | 1 |
| Sevinc, A | 1 |
| Camci, C | 1 |
| Turk, HM | 1 |
| Karakok, M | 1 |
| Akgul, B | 1 |
1 other study available for anastrozole and Focal Segmental Glomerulosclerosis
| Article | Year |
|---|---|
Anastrozole-associated sclerosing glomerulonephritis in a patient with breast cancer.
Topics: Aged; Anastrozole; Antineoplastic Agents, Hormonal; Atrophy; Breast Neoplasms; Fatal Outcome; Female | 2007 |